Home › NCT06820385

Testing a WearabLE Artificial Intelligence-POwered Device For OPtimal DAily RaDiation Therapy Using Image Guidance

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

1. Age ≥18 years.
2. Ability to voluntarily drink water and fill an intact bladder preparing for radiation treatment.
3. Patients (not healthy volunteers) can have any pelvic malignancy (e.g., rectal cancer, prostate cancer, bladder cancer, cervical cancer, anal cancer, endometrial cancer, sarcoma, bone metastatic lesions) being treated with radiation therapy.
4. Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria:

1. Prior allergic reaction to ultrasound gel, which is composed of water and propylene glycol.
2. Inability to place device on skin (excessive hair or body habitus that is prohibitive).

About the study

This is a device feasibility study to determine the feasibility of automatically predicting time to treatment readiness using a wearable imaging device (Fullyet) in both healthy volunteers and patients with pelvic malignancies undergoing radiation therapy.

What is being tested

• Fullyet Device and CT Scans (device)
• Fullyet Device and MRI Scans (device)

Sponsor: Medical College of Wisconsin · Participants: 15 · Started: May 2, 2025

Contact the study team

• Medical College of Wisconsin Cancer Center Clinical Trials Office · Phone: 866-680-0505

Official record on ClinicalTrials.gov — NCT06820385

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.